Authors:
Bungard, TJ
Ghali, WA
McAlister, FA
Buchan, AM
Cave, AJ
Hamilton, PG
Mitchell, LB
Shuaib, A
Teo, KK
Tsuyuki, RT
Citation: Tj. Bungard et al., Physicians' perceptions of the benefits and risks of warfarin for patientswith nonvalvular atrial fibrillation, CAN MED A J, 165(3), 2001, pp. 301-302
Citation: Kl. Olson et al., Cholesterol risk management: A systematic examination of the gap from evidence to practice, PHARMACOTHE, 21(7), 2001, pp. 807-817
Citation: Tj. Bungard et al., Adequacy of anticoagulation in patients with atrial fibrillation coming toa hospital, PHARMACOTHE, 20(9), 2000, pp. 1060-1065
Authors:
Tsuyuki, RT
McAlister, FA
Bungard, TJ
Ghali, WA
Teo, KK
Citation: Rt. Tsuyuki et al., Warfarin therapy for atrial fibrillation: The patient's preference is important - In Reply, ARCH IN MED, 160(15), 2000, pp. 2403-2403
Citation: Tj. Bungard et Pb. Kale-pradhan, Prokinetic agents for the treatment of postoperative ileus in adults: A review of the literature, PHARMACOTHE, 19(4), 1999, pp. 416-423